NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-HL-18-640 from the NIH Guide for Grants and Contracts
Notice NOT-HD-18-014 from the NIH Guide for Grants and Contracts
Notice NOT-OD-18-203 from the NIH Guide for Grants and Contracts
Notice NOT-OD-18-204 from the NIH Guide for Grants and Contracts
Notice NOT-HL-18-641 from the NIH Guide for Grants and Contracts
Notice NOT-DA-18-024 from the NIH Guide for Grants and Contracts
Notice NOT-HL-18-642 from the NIH Guide for Grants and Contracts
Notice NOT-HS-18-011 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-18-853 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support research to elucidate the chemical features of non-native molecules that cross the blood-testis and/or blood-epidydimal barriers.
Notice NOT-OD-18-208 from the NIH Guide for Grants and Contracts
Notice NOT-DK-18-018 from the NIH Guide for Grants and Contracts
Notice NOT-CA-18-094 from the NIH Guide for Grants and Contracts
Notice NOT-RM-18-017 from the NIH Guide for Grants and Contracts
Notice NOT-AI-18-039 from the NIH Guide for Grants and Contracts
Notice NOT-DA-18-016 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-18-036 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to continue a Leadership Group (LG) for a Clinical Research Network on Antibacterial Resistance (AR), which was initiated to develop, implement, and manage a clinical research program to address key clinical research questions in AR. The LG is a cohesive program dependent on the highly integrated and complimentary activities of the four centers that comprise the network: Scientific Leadership Center (SLC), Clinical Operations Center (COC), Laboratory Center (LC) and Statistics and Data Management Center (SDMC).
Notice NOT-HL-18-621 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DC-19-002 from the NIH Guide for Grants and Contracts. The NIDCD Temporal Bone Registry is a national research resource for human auditory and vestibular research. Its fundamental purpose is to coordinate information about specimens of the human ear and to recruit potential temporal bone donors. The Registry coordinates specimen collection, information recording and data management of specimens, and provides public information, including an up-to-date website about human ear specimens for research. It is not a simple database or tissue bank for human ear specimens. Applications are encouraged that will enhance, promote, and support critical research on the human middle and inner ear that cannot be done in living humans. Use of temporal bone specimens also provides an opportunity for translation from critical animal models to human models for auditory and vestibular research. This initiative will support the Registry by cooperative agreement, to: continue to develop and maintain a growing database for access to detailed information about the location, condition, and other bioinformatics data about new and archival human temporal bone tissues around the country that are available as resources for auditory and vestibular research; communicate with scientific and clinical researchers to disseminate information about the resources available; maintain a well-organized nationwide network of on-call experts for timely post-mortem harvesting of temporal bone tissues; develop and implement a strategy for receipt of harvested tissue by nearby temporal bone laboratories; develop new methods or techniques for donor recruitment and post-mortem tissue procurement; communicate with pledges for tissue donation combined with relevant medical histories that will allow linking functional disorders to morphological, biochemical and genetic pathologies; provide education/outreach to the scientific community and to the public about temporal bone donations.
Funding Opportunity PA-18-851 from the NIH Guide for Grants and Contracts. The purpose of this administrative supplement is to facilitate translational research partnerships between junior researchers with quantitative backgrounds (in engineering or computational or physical sciences) and junior clinician-scientists from active CTSA institutions (PAR-15-304, PAR-18-464). The supplement will support the quantitative researcher, the NIBIB Translational Research Scholar, contingent upon his/her collaborating with a clinician-scientist KL2 scholar, the "partnering clinician-scientist". The partnering clinician-scientist will be supported independently of this supplement through the parent KL2 award throughout the duration of the proposed supplement. Both team members will be selected by the KL2 PI. The KL2 PI will assist the NIBIB Translational Research Scholar and the partnering clinician-scientist in developing a translational research project aligned with NIBIBs research mission under the guidance of their identified basic and clinical/translational science mentors. Based on this project, the KL2 PI will submit a supplement request under this FOA.
Funding Opportunity PA-18-852 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to incentivize collaborative, multidisciplinary research across a broad area of challenging topics in basic cancer biology. These supplement applications must propose a collaboration between at least two researchers, one being the PI of the parent NCI grant. Awarded supplements will leverage and extend currently funded cancer research in the parent grant.